• Je něco špatně v tomto záznamu ?

Anthelmintic Flubendazole and its potential use in anticancer therapy

K. Čáňová, L. Rozkydalová, E. Rudolf

. 2017 ; 60 (1) : 5-11. [pub] 20170411

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc17026009

Flubendazole is a widely used anthelmintic drug belonging to benzimidazole group. The molecular mechanism of action of flubendazole is based on its specific binding to tubulin, which results in disruption of microtubule structure and function, and in the interference with the microtubule-mediated transport of secretory vesicles in absorptive tissues of helminths. The microtubule-disrupting properties of benzimidazole derivatives raised recently interest in these compounds as possible anti-cancer agents. In this minireview flubendazole effects towards selected human malignant cells including myeloma, leukemia, neuroblastoma, breast cancer, colorectal cancer and melanoma are discussed along with basic data on its pharmacokinetics, metabolism and toxicity.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17026009
003      
CZ-PrNML
005      
20170906123125.0
007      
ta
008      
170824s2017 xr f 000 0|eng||
009      
AR
024    7_
$a 10.14712/18059694.2017.44 $2 doi
035    __
$a (PubMed)28399389
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Čáňová, Kristýna $u Charles University, Faculty of Medicine in Hradec Králové, Department of Medical Biology and Genetics, Hradec Králové, Czech Republic $7 xx0257567
245    10
$a Anthelmintic Flubendazole and its potential use in anticancer therapy / $c K. Čáňová, L. Rozkydalová, E. Rudolf
520    9_
$a Flubendazole is a widely used anthelmintic drug belonging to benzimidazole group. The molecular mechanism of action of flubendazole is based on its specific binding to tubulin, which results in disruption of microtubule structure and function, and in the interference with the microtubule-mediated transport of secretory vesicles in absorptive tissues of helminths. The microtubule-disrupting properties of benzimidazole derivatives raised recently interest in these compounds as possible anti-cancer agents. In this minireview flubendazole effects towards selected human malignant cells including myeloma, leukemia, neuroblastoma, breast cancer, colorectal cancer and melanoma are discussed along with basic data on its pharmacokinetics, metabolism and toxicity.
650    _2
$a stárnutí buněk $x účinky léků $7 D016922
650    _2
$a viabilita buněk $7 D002470
650    _2
$a vztah mezi dávkou a účinkem léčiva $7 D004305
650    _2
$a lidé $7 D006801
650    _2
$a leukemie $x farmakoterapie $7 D007938
650    _2
$a mebendazol $x analogy a deriváty $x terapeutické užití $7 D008463
650    _2
$a mikrotubuly $x metabolismus $7 D008870
650    _2
$a mnohočetný myelom $x farmakoterapie $7 D009101
650    _2
$a tubulin $x metabolismus $7 D014404
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Rozkydalová, Lucie $u Charles University, Faculty of Pharmacy in Hradec Králové, Department of Pharmacology, Hradec Králové, Czech Republic $7 _AN092758
700    1_
$a Rudolf, Emil, $u Charles University, Faculty of Medicine in Hradec Králové, Department of Medical Biology and Genetics, Hradec Králové, Czech Republic $d 1970- $7 xx0076300
773    0_
$w MED00010947 $t Acta Medica (Hradec Kralove) $x 1211-4286 $g Roč. 60, č. 1 (2017), s. 5-11
856    41
$u https://actamedica.lfhk.cuni.cz/media/pdf/18059694.2017.44.pdf $y plný text volně přístupný
910    __
$a ABA008 $b A 3077 $c 1072 $y 4 $z 0
990    __
$a 20170824 $b ABA008
991    __
$a 20170904135941 $b ABA008
999    __
$a ok $b bmc $g 1246208 $s 986956
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 60 $c 1 $d 5-11 $e 20170411 $i 1211-4286 $m Acta Medica $n Acta Med. (Hradec Král.) $x MED00010947
LZP    __
$b NLK118 $a Pubmed-20170824

Najít záznam

Citační ukazatele

Možnosti archivace